Taylor & Francis Group partners with the Biotech Research Society, India (BRSI) to amplify India’s biotechnology research - Taylor & Francis Newsroom

We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

Taylor & Francis Group news

23rd March 2022

Taylor & Francis Group partners with the Biotech Research Society, India (BRSI) to amplify India’s biotechnology research

Researcher setting up genetic samples and primers for polymerase chain reaction, or PCR, a laboratory technique used to make multiple copies of a segment of DNA.

Taylor & Francis Group is pleased to announce a publishing partnership with the Biotech Research Society, India (BRSI).  

The aim is that BRSI members promote their biotechnology research to a wider audience by publishing via Taylor & Francis Group global publications. Under the terms of the partnership, the BRSI will recommend prospective authors from its membership to Taylor & Francis. 

Taylor & Francis is one of the leading research publishers in the world. The BSRI is a non-profit, scientific, professional society dedicated to promoting excellence and competence in the field of biotechnology. It promotes biotechnology research and development and encourages collaboration between academic institutes and biotechnology industries. It also shares knowledge through lectures, seminars, and symposia on scientific programs and societal missions. 

Prof Ashok Pandey, BRSI Distinguished Fellow and Distinguished Scientist at the Centre for Innovation and Translational Research, CSIR-Indian Institute of Toxicology Research, said:  

“It’s great that the BSRI and Taylor & Francis Group have come together and signed an agreement on the publication of books together. This fulfills one of their major aims, i.e., dissemination of scientific and technological knowledge and developments for the benefits of the scientific community as well as others such as industries and policy makers through publications. I am confident that this will mutually help all the stakeholders, namely, the members of the BRSI, Taylor & Francis, and the readers.” 

Nitasha Devasar, Managing Director, Taylor & Francis India & South Asia; Vice President and Commercial Lead, India, South Asia & Africa, said:  

“Taylor & Francis is delighted to collaborate with the Biotech Research Society, India and add value for members. This partnership will aid impact and amplification of high-quality Indian research in the rapidly growing field of biotechnology.” 

Dr Gagandeep Singh, Senior Publisher at CRC Press, Taylor & Francis Group, said:  

Taylor & Francis is very excited to work with Biotech Research Society of India (BRSI) and looking forward to developing a co-branded organic commissioning program alongside investing in strategic initiatives aimed at mutual benefit of both organizations.” 

According to a report by India Brand Equity Foundation, India is among the top 12 destinations for biotechnology worldwide and has more than 2,700 biotechnology start-ups and more than 2,500 biotechnology companies. The same report says the Indian biotechnology industry is forecasted to be worth US$ 150 billion by 2025. 

Taylor & Francis Group’s growing list of authoritative biotechnology titles range from fundamental concepts to advanced applications. The collection explores microbiology, virology, biochemistry, and computational biology as well as topics relevant to a wider audience like ecology and environmental biology. Types of books include textbooks, handbooks, and laboratory manuals in attractive print and digital formats.